|
PHC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.167960E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.778500E-03 |
| Normal-vs-Stage2 |
1.576360E-01 |
| Normal-vs-Stage3 |
1.573700E-02 |
| Normal-vs-Stage4 |
1.466760E-01 |
| Stage1-vs-Stage2 |
4.240200E-01 |
| Stage1-vs-Stage3 |
9.332400E-01 |
| Stage1-vs-Stage4 |
4.267000E-01 |
| Stage2-vs-Stage3 |
4.448600E-01 |
| Stage2-vs-Stage4 |
9.854600E-01 |
| Stage3-vs-Stage4 |
4.484200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.207850E-02 |
| Normal-vs-AfricanAmerican |
1.285680E-02 |
| Normal-vs-Asian |
6.017700E-02 |
| Caucasian-vs-AfricanAmerican |
1.259970E-01 |
| Caucasian-vs-Asian |
8.944000E-01 |
| AfricanAmerican-vs-Asian |
1.870990E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.020400E-03 |
| Normal-vs-Female |
2.270300E-02 |
| Male-vs-Female |
3.381400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.709510E-02 |
| Normal-vs-Age(41-60Yrs) |
1.160530E-03 |
| Normal-vs-Age(61-80Yrs) |
3.695200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.557800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.410600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.705800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.148000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.404600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.227400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.117900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.304800E-03 |
| Classical-VS-Follicular |
1.315630E-03 |
| Classical-VS-Other |
9.694200E-01 |
| Classical-VS-Normal |
7.829400E-04 |
| Tall-VS-Follicular |
7.184200E-01 |
| Tall-VS-Other |
3.831000E-01 |
| Tall-VS-Normal |
3.064600E-01 |
| Follicular-VS-Other |
3.105000E-01 |
| Follicular-VS-Normal |
5.329200E-01 |
| Other-VS-Normal |
1.327850E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.679600E-02 |
| Normal-vs-N1 |
6.042800E-01 |
| N0-vs-N1 |
1.015450E-01 |
|
|
